Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Approval save search
Second Sight Medical Products, Inc. Receives FDA Approval for the Argus 2s Retinal Prosthesis System
Published: 2021-03-05 (Crawled : 15:00) - biospace.com/
EYES | $4.14 -0.24% 3.14%
|
Health Technology
|
| O: 60.14%
H: 331.88%
C: 152.84%
fda fda approval retina approval
Trevena Announces Approval of OLINVYK in China
Published: 2023-05-08 (Crawled : 11:00) - globenewswire.com
TRVN | $0.388 4.81% -2.27% 0
|
Health Technology
|
| O: 23.32%
H: 322.19%
C: 300.31%
approval olinvyk china
Scopus BioPharma Announces FDA Approval of IND Application for Lead Drug Candidate
Published: 2021-05-24 (Crawled : 14:00) - globenewswire.com
SCPS | $0.1682
|
|
| O: -3.69%
H: 247.56%
C: 78.57%
fda biopharma fda approval drug approval application
Panbela Therapeutics Announces US WorldMeds NDA Approval for Eflornithine (DFMO) in Pediatric Neuroblastoma
Published: 2023-12-18 (Crawled : 13:00) - globenewswire.com
PBLA | News | $0.42 -11.54% -6.31% 0
|
Professional, Scientific, and T...
|
| O: 29.1%
H: 177.92%
C: 71.16%
approval therapeutics
Endo Announces Approval of XCOPRI™ (cenobamate tablets) in Canada
Published: 2023-06-29 (Crawled : 12:20) - biospace.com/
ENDPQ | News | $0.0007 -50.0% 1K
|
n/a
|
| O: -50.0%
H: 150.0%
C: 125.0%
approval canada
Earth Science Tech, Inc., Appoints New CFO and Shares that RxCompoundStore.com, LLC. has Received Approval to Ship into Additional States
Published: 2023-07-17 (Crawled : 20:00) - globenewswire.com
ETST P | $0.068 4.61% 0
|
Manufacturing
|
| O: -9.09%
H: 130.0%
C: 130.0%
approval
Ainos COVID-19 Antigen Self-Test Receives Approval for Sale in Taiwan
Published: 2022-06-21 (Crawled : 12:00) - biospace.com/
AIMD | $1.02 810
|
Manufacturing
|
| O: -53.53%
H: 121.08%
C: 30.32%
covid-19 approval
AVEO Oncology Announces U.S. FDA Approval of FOTIVDA® (tivozanib) for the Treatment of Adult Patients with Relapsed or Refractory Advanced Renal Cell Carcinoma
Published: 2021-03-10 (Crawled : 21:01) - biospace.com/
AVEO | $15.0 0.0% 0
|
Health Technology
|
| O: 1.73%
H: 86.98%
C: 85.89%
treatment fda renal fda approval approval cell carcinoma
1847 Holdings Announces NYSE American Listing Approval
Published: 2022-04-27 (Crawled : 17:00) - globenewswire.com
EFSH 4 | $2.79 51K
|
Professional, Scientific, and T...
|
| O: 0.0%
H: 83.67%
C: 38.78%
approval
Sidus Space Secures NOAA Approval to Provide Imaging Services to Government and Commercial Customers
Published: 2024-01-03 (Crawled : 13:30) - sidusspace.com
SIDU | $3.41 0.87% 150
|
|
| O: 11.76%
H: 73.04%
C: 49.42%
services approval space commercial imaging
YS BIOPHARMA AND SUMMIT HEALTHCARE ANNOUNCE SHAREHOLDER APPROVAL OF BUSINESS COMBINATION
Published: 2023-03-14 (Crawled : 21:00) - prnewswire.com
SMIH | $9.0998 48.36% 0
|
|
| O: 5.77%
H: 67.64%
C: 18.18%
biopharma business approval
Silo Wellness Announces LOI to Acquire NUGL/Kaya in a Transaction Valued at CAD $43,289,624.60; CSE to Halt Trading Until Shareholder Approval
Published: 2023-08-29 (Crawled : 09:00) - globenewswire.com
NUGL | $0.0069 38.0% -69.01% 0
|
Administrative and Support and ...
|
| O: 64.84%
H: 62.0%
C: -35.33%
approval wellness acquire
Energous Corporation Announces First Customer Product Approval from FCC
Published: 2018-12-27 (Crawled : 14:59) - globenewswire.com
WATT | $1.36 0.74% -0.37% 0
|
Electronic Technology
|
| O: 31.66%
H: 59.04%
C: 16.75%
approval
FDA grants accelerated approval for ADUHELM™ as the first and only Alzheimer’s disease treatment to address a defining pathology of the disease
Published: 2021-06-07 (Crawled : 18:00) - globenewswire.com
BIIB | $200.31 3.69% 470K
|
Health Technology
|
| O: 3.22%
H: 58.64%
C: 34.03%
disease alzheimer treatment fda approval alzheimer’s alzheimer's disease alzheimer's
NRx Pharmaceuticals Announces First Successful Commercial Formulation for ZYESAMI™ (aviptadil), Enabling Volume Manufacture, Shipping, and Stockpiling of COVID-19 Medication Subject to Regulatory Approval
Published: 2021-07-22 (Crawled : 12:00) - biospace.com/
NRXP 5 d | $3.05 1.67% 3.23% 2.3K
|
Manufacturing
|
| O: 15.43%
H: 56.64%
C: 40.96%
covid approval aviptadil commercialization
Armstrong Flooring Receives Approval for Additional Financing
Published: 2022-05-17 (Crawled : 00:00) - globenewswire.com
AFI | $0.3512 0.57%
|
Producer Manufacturing
|
| O: 19.97%
H: 54.12%
C: 26.47%
approval
ReShape Lifesciences® Receives FDA PMA Supplement Approval for its Next-Generation Lap-Band® 2.0 FLEX
Published: 2023-12-12 (Crawled : 21:00) - globenewswire.com
RSLS | $0.1705 2.16% 3.93% 3.5K
|
Manufacturing
|
| O: 59.44%
H: 47.43%
C: -3.95%
lifesciences fda approval
INOVIO Receives FDA Feedback that Data from Completed Phase 1/2 Trial of INO-3107 Can Be Used to Submit a BLA Under Accelerated Approval Program
Published: 2023-10-10 (Crawled : 12:30) - inovio.com
INO | $10.37 3.49% 3.09% 0
|
Health Technology
|
| O: 13.73%
H: 45.31%
C: 23.98%
ino-3107 fda approval program trial
ANI Pharmaceuticals Announces FDA Approval of Purified Cortrophin™ Gel for Multiple Indications Including Multiple Sclerosis, Rheumatoid Arthritis and Nephrotic Syndrome
Published: 2021-11-01 (Crawled : 12:00) - biospace.com/
ANIP S | $66.14 0.79% 0.77% 0
|
Health Technology
|
| O: 9.77%
H: 41.84%
C: 31.63%
multiple sclerosis fda rheumatoid arthritis fda approval sclerosis approval syndros
U.S. District Court Upholds Final Judgment for XIFAXAN(R) 550 mg That Prevents FDA Approval of Norwich’s Abbreviated New Drug Application Until 2029
Published: 2023-05-17 (Crawled : 22:00) - biospace.com/
BHC | $8.53 0.95% 0.0% 500
|
Health Technology
|
| O: 1.0%
H: 40.79%
C: 22.86%
fda drug approval application
Gainers vs Losers
| 71% | 29% |
Top 10 Gainers
CZOO | $9.98 100.0% 330K
|
AMST | $3.48 74.0% 21M
|
Technology Services
BOF | $1.78 52.14% 15M
|
CSSE 4 | $0.2184 43.4% 36M
|
Consumer Services
ACB | $7.32 16.56% 780K
|
Process Industries
AEYE | $15.42 14.39% 150K
|
Technology Services
CGC | $8.835 12.55% 740K
|
Process Industries
BW | News | $1.0002 9.05% 190K
|
Electronic Technology
DXYZ 4 | $30.91 8.49% 73K
|
n/a
CMTL | $1.695 7.28% 110K
|
Electronic Technology
Your saved searches
Save your searches and get alerts when important news are released.